Lexicon did manage to get approval for type 1 diabetes in Europe, but the product was never launched there for commercial ...

The NHS often relies on professional interpreters and translation services to bridge these gaps, but this comes at a ...

The 4th mRNA-Based Therapeutics Summit Europe returns to Frankfurt, Germany as the industry’s premier forum dedicated to ...

Investors in the cell therapy industry are actively looking into solid tumours, autoimmune indications and novel engineering ...

Building on 7 years of success, the 8th Antigen-Specific Immune Tolerance Summit is back - the only conference dedicated to ...

Join us at the 2nd Protein Degradation for CNS Summit - an unparalleled event dedicated to delivering protein degraders to ...

Join the ultimate European gathering of microbiome innovators dedicated to translating groundbreaking research into viable, ...

CHEERS-AI – or Consolidated Health Economic Evaluation Reporting Standards for Interventions That Use Artificial Intelligence ...

If approved, the less burdensome version of Leqembi could be used to treat patients at home or in medical facilities, help ...

The fine of €462.6 million ($503 million) is believed to be the largest imposed on a pharma company for breaking antitrust ...

Beyond environmental concerns, the 'S' in ESG encompasses social factors like diversity and inclusion, labour standards, ...

The new accelerated approval covers the use of Scemblix for newly diagnosed patients with Philadelphia chromosome-positive ...